CVRX Company Profile and Key Details

CVRx, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.18. This means the shares are trading below this model’s fair value.

CVRX has shown weak momentum, losing -23.53% over the past week and -43.82% over the past quarter, though year-to-date performance is down -21.27%. Short-term trend indicators are bullishly aligned (SMA20 25.42%, SMA50 16.43%, SMA200 5.35%). The stock’s 14-day RSI is 64.66 (firm momentum), while the ATR of 0.7 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -42.51% below its high and over 87.47% above its low. Average 10-day trading volume of 577.03 thousand shares is significantly above the 3-month average of 360.38 thousand, indicating heightened recent market interest.

CVRx, Inc. generated EPS of -$2.04 over the past year. Five-year average earnings growth is -22.44%. Wall Street analysts project EPS growth of 6.41% annually over the next five years. The latest quarter delivered EPS of -$0.50. The next quarter is forecast at -$0.52. Next year's EPS is expected at $4.05. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $13.00 to $10.00. The high target offers 117.03% upside. The low target suggests 66.94% downside. The mean target is $11.20. This offers 86.98% upside. CVRx, Inc. earnings surprise history is a mixed track record. The quarter that ended May 11, 2026, missed forecasts by -1.96%. The prior quarter beat by 9.52%. Over the last six quarters, Apple has recorded several small beats. These include 16.22% in February 04, 2025.

CVRx, Inc. has 26.07 million shares outstanding. The public float is 17.96 million shares, elevated short interest at 9.91% of float. This equals 1.91 million shares. The short ratio is 6.94 days. Institutional investors hold 70.92% of the float. Insiders own 4.31%. JOHNSON & JOHNSON holds 4.02 million shares, NEW ENTERPRISE ASSOCIATES 10 L P has 2.03 million shares and Nielsen Kirk G. has 1.91 million shares. Over the past six months, insider transactions show net selling. They sold 41.05 thousand shares across 9 transactions.

CVRx, Inc. (NASDAQ:CVRX) closed at $5.99 USD, gaining $0.25 (4.36%) from the previous close of $5.74. The stock is currently mid-range between its 52-week high and low $4.37 and $11.30. With a market capitalization of about $158.32 million, CVRx, Inc. is classified as a micro-cap and shows market-like volatility (beta ~0.87). Key stats such as the average daily volume over the past year has been around 350.25 thousand shares, trading with heavier-than-usual volume. Headquartered in Minneapolis, MN, CVRx, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Kevin Hykes, the company employs approximately 206 people and listed since June 30, 2021. CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.

CVRx, Inc. trades at a P/E ratio of -3.01, slightly below the S&P 500 average, with a price-to-sales ratio of 2.69 and a price-to-book ratio of 5.44 trading at moderately above to book value. The P/FCF stands at -3.95, also above market averages.

Our AI price prediction model suggests that CVRx, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -16.69%, with price expected at $4.99 by May 29, 2026, within a range of $4.30 to $5.70 3-Month Outlook: Projected rise of 98.33%, reaching $11.88 by August 13, 2026, with a range of $11.16 to $12.61. 1-Year Outlook: Projected gain of 75.46%, with price at $10.51 by May 14, 2027, within a range of $0.00 to $20.21.

CVRx, Inc. (NASDAQ:CVRX) shares are down -21.27% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows CVRx, Inc. trading at a premium to the broader market with a P/E of -3.01. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $16.21, suggesting 170.62% upside. Our AI forecast model points to short-term weakness (-16.69% over two weeks), a medium-term rise (98.33% over three months), and a longer-term gain (75.46% over one year), with expected trading ranges indicating moderate volatility.